PLA2G7 Antikörper (AA 49-441) (HRP)
-
- Target Alle PLA2G7 (Lp-PLA2) Antikörper anzeigen
- PLA2G7 (Lp-PLA2) (Lipoprotein-Associated phospholipase A2 (Lp-PLA2))
-
Bindungsspezifität
- AA 49-441
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PLA2G7 Antikörper ist konjugiert mit HRP
-
Applikation
- ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Platelet-activating factor acetylhydrolase protein (49-441AA)
- Isotyp
- IgG
- Top Product
- Discover our top product Lp-PLA2 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- PLA2G7 (Lp-PLA2) (Lipoprotein-Associated phospholipase A2 (Lp-PLA2))
- Andere Bezeichnung
- PLA2G7 (Lp-PLA2 Produkte)
- Synonyme
- LDL-PLA2 antikoerper, LP-PLA2 antikoerper, PAFAD antikoerper, PAFAH antikoerper, Lp-PLA2 antikoerper, PAF-AH antikoerper, R75400 antikoerper, zgc:77563 antikoerper, phospholipase A2 group VII antikoerper, phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) antikoerper, PLA2G7 antikoerper, Pla2g7 antikoerper, pla2g7 antikoerper
- Hintergrund
-
Background: Modulates the action of platelet-activating factor (PAF) by hydrolyzing the sn-2 ester bond to yield the biologically inactive lyso-PAF. Has a specificity for substrates with a short residue at the sn-2 position. It is inactive against long-chain phospholipids.
Aliases: Platelet-activating factor acetylhydrolase precursor antibody, 1 alkyl 2 acetylglycerophosphocholine esterase antibody, 1-alkyl-2-acetylglycerophosphocholine esterase antibody, 2 acetyl 1 alkylglycerophosphocholine esterase antibody, 2-acetyl-1-alkylglycerophosphocholine esterase antibody, EC 3.1.1.47 PAF acetylhydrolase PAF 2-acylhydrolase LDL associated phospholipase A2 antibody, Group VIIA phospholipase A2 antibody, Group-VIIA phospholipase A2 antibody, gVIIA PLA2 antibody, gVIIA-PLA2 antibody, LDL associated phospholipase A2 antibody, LDL PLA(2) antibody, LDL PLA2 antibody, LDL-associated phospholipase A2 antibody, LDL-PLA(2) antibody, Lipoprotein associated phospholipase A2 antibody, LP PLA2 antibody, PAF 2 acylhydrolase antibody, PAF 2 acylhydrolase LDL associated phospholipase A2 antibody, PAF 2-acylhydrolase antibody, PAF acetylhydrolase antibody, PAFA_HUMAN antibody, PAFAD antibody, PAFAH antibody, Phospholipase A2, group VII (platelet activating factor acetylhydrolase, plasma) antibody, PLA2G7 antibody, Platelet activating factor acetylhydrolase 2 antibody, Platelet activating factor acetylhydrolase antibody, Platelet-activating factor acetylhydrolase antibody
- UniProt
- Q13093
- Pathways
- Peptide Hormone Metabolism
-